DashboardAll companies
Run this on your own research
Healthcare · Drug Manufacturers - Specialty & Generic

Hanall Biopharma Co. Ltd.

009420KRX₩51,100₩0 (0.00%)Market closed
Filing DateReportFiler
20261113Quarterly Report (2026.09)한올바이오파마
20261028Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20261006Executive and Major Shareholder Ownership Report국민연금공단
20260814Half-Year Report (2026.06)한올바이오파마
20260731Investor Relations (IR) Event (Notice)한올바이오파마
20260729Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20260722Amended: Material Event Relevant to Investment Decisions한올바이오파마
20260722Material Event Relevant to Investment Decisions한올바이오파마
20260702Executive and Major Shareholder Ownership Report국민연금공단
20260701Report on Large Shareholdings (Short Form)국민연금공단
20260630Sustainability Report (Voluntary)한올바이오파마
20260601Corporate Governance Report한올바이오파마
20260528Investor Relations (IR) Event (Notice)한올바이오파마
20260520Amended: Material Event Relevant to Investment Decisions한올바이오파마
20260515Quarterly Report (2026.03)한올바이오파마
20260506Report on Results of Treasury Share Disposal한올바이오파마
20260506Executive and Major Shareholder Ownership Report박승국
20260506Executive and Major Shareholder Ownership Report정승원
20260506Executive and Major Shareholder Ownership Report안혜경
20260506Change in Shares Held by the Largest Shareholder한올바이오파마
20260429Material Event Report (Treasury share disposal)한올바이오파마
20260429Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20260413Investor Relations (IR) Event (Notice)한올바이오파마
20260407Executive and Major Shareholder Ownership Report국민연금공단
20260402Material Event Relevant to Investment Decisions한올바이오파마
20260401Report on Large Shareholdings (Short Form)국민연금공단
20260327Appointment, Dismissal or Resignation of an Independent Director한올바이오파마
20260326Change of CEO (Notice)한올바이오파마
20260326Results of the Annual General Meeting한올바이오파마
20260318Annual Report (2025.12)한올바이오파마
20260311Report on Results of Treasury Share Disposal한올바이오파마
20260309Material Event Report (Treasury share disposal)한올바이오파마
20260309Submission of Audit Report한올바이오파마
20260303Report on Results of Treasury Share Disposal한올바이오파마
20260225Notice of Shareholders' Meeting한올바이오파마
20260225Material Event Report (Treasury share disposal)한올바이오파마
20260225Resolution to Convene a Shareholders' Meeting한올바이오파마
20260121Change of 30% or More in Revenue or Profit (15% for Large Companies)한올바이오파마
20260121Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20260102Report on Large Shareholdings (Short Form)국민연금공단
20251219Amended: New Facility Investment한올바이오파마
20251215Record Date or Shareholder Register Closure한올바이오파마
20251125Investor Relations (IR) Event (Notice)한올바이오파마
20251125Investor Relations (IR) Event (Notice)한올바이오파마
20251114Quarterly Report (2025.09)한올바이오파마
20251029Amended: Ad-Hoc Disclosure Obligation (Fair disclosure)한올바이오파마
20251029Report on Results of Treasury Share Disposal한올바이오파마
20251029Change in Shares Held by the Largest Shareholder한올바이오파마
20251029Executive and Major Shareholder Ownership Report정승원
20251029Ad-Hoc Disclosure Obligation (Fair disclosure)한올바이오파마
20251029Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20251029Material Event Report (Treasury share disposal)한올바이오파마
20250925Amended: Corporate Governance Report한올바이오파마
20250814Half-Year Report (2025.06)한올바이오파마
20250730Report on Results of Treasury Share Disposal한올바이오파마
20250730Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20250730Material Event Report (Treasury share disposal)한올바이오파마
20250602Report on Results of Treasury Share Disposal한올바이오파마
20250602Change in Shares Held by the Largest Shareholder한올바이오파마
20250602Executive and Major Shareholder Ownership Report정승원
20250602Material Event Report (Treasury share disposal)한올바이오파마
20250530Corporate Governance Report한올바이오파마
20250515Quarterly Report (2025.03)한올바이오파마
20250430Report on Results of Treasury Share Disposal한올바이오파마
20250430Change in Shares Held by the Largest Shareholder한올바이오파마
20250430Executive and Major Shareholder Ownership Report박승국
20250430Material Event Report (Treasury share disposal)한올바이오파마
20250430Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20250414Report on Results of Treasury Share Acquisition한올바이오파마
20250410Investor Relations (IR) Event (Notice)한올바이오파마
20250401Report on Large Shareholdings (Short Form)국민연금공단
20250328Executive and Major Shareholder Ownership Report국민연금공단
20250327Material Event Relevant to Investment Decisions한올바이오파마
20250327Amended: Results of the Annual General Meeting한올바이오파마
20250326Results of the Annual General Meeting한올바이오파마
20250324Material Event Report (Treasury share acquisition)한올바이오파마
20250320Material Event Relevant to Investment Decisions한올바이오파마
20250318Annual Report (2024.12)한올바이오파마
20250318Material Event Relevant to Investment Decisions한올바이오파마
20250306Submission of Audit Report한올바이오파마
20250225Notice of Shareholders' Meeting한올바이오파마
20250225Resolution to Convene a Shareholders' Meeting한올바이오파마
20250225Report on Results of Treasury Share Disposal한올바이오파마
20250225Executive and Major Shareholder Ownership Report안혜경
20250225Material Event Report (Treasury share disposal)한올바이오파마
20250211Report on Results of Treasury Share Disposal한올바이오파마
20250211Change in Shares Held by the Largest Shareholder한올바이오파마
20250211Executive and Major Shareholder Ownership Report안혜경
20250211Executive and Major Shareholder Ownership Report박승국
20250211Material Event Report (Treasury share disposal)한올바이오파마
20250122Change of 30% or More in Revenue or Profit (15% for Large Companies)한올바이오파마
20250122Preliminary Earnings (Consolidated) (Fair disclosure)한올바이오파마
20250108Executive and Major Shareholder Ownership Report국민연금공단
20241226Executive and Major Shareholder Ownership Report국민연금공단
20241216Record Date or Shareholder Register Closure한올바이오파마
20241120Executive and Major Shareholder Ownership Report국민연금공단
20241115Executive and Major Shareholder Ownership Report국민연금공단
20241114Quarterly Report (2024.09)한올바이오파마
20241112Executive and Major Shareholder Ownership Report국민연금공단
20241107Executive and Major Shareholder Ownership Report국민연금공단
DART (Korea FSS Electronic Disclosure)
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Hanall Biopharma Co. Ltd. (009420) Filings & Insider Trades | AlphaLenz